Brought to you by 
ViewRay closes $141mm public stock sale
21 Jun 2021
Executive Summary
| ViewRay Inc. netted $141mm through the public sale of 47.8mm common shares (including the overallotment) at $3.13. The company markets the MRIdian MRI-guided radiation system, and will use the offering proceeds for capital expenditures and continued R&D expenses. Funds could also support recently-announced relationships with Elekta and Medtronic; the company entered into non-binding memorandums of understanding to enter into collaborations with each firm. Elekta took a 9.9% stake in ViewRay through the purchase of 11.5mm shares in the public offering, in connection with the MOU. |
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ViewRay closes $141mm public stock sale
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice